ArticleScientific reports2025
Nomogram based on CT and clinical features to predict R0 resection in patients with stage IIB-IV epithelial ovarian cancer: a multi-center study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To develop a nomogram based on CT and clinical features to predict R0 resection in patients with stage IIB-IV epithelial ovarian cancer (EOC). 209 patients with stage IIB-IV EOC from three independent medical institutions were stratified into training cohort (from institutions 1 and 2, n = 144) and independent validation cohort (from institution 3, n = 65). Univariate and multivariate logistic analyses of CT and clinical features obtained within two weeks before debulking surgery were used to determine the independent predictors of R0 resection in the training cohort. Nomogram was developed based on the predictors. Receiver operating characteristic (ROC) curves and calibration curves were performed to evaluate the predictive performance of the nomogram. R0 resection was achieved in 66.00 and 61.50% patients in the training and validation cohorts, respectively. In the training cohort, overall peritoneal cancer index based on CT (CT-PCI) (OR 1.245, P < 0.001), serum human epididymis protein4 (HE4) level (OR 1.003, P = 0.012), and neutrophil-to-lymphocyte ratio (NLR) (OR 1.272, P = 0.031) were independent predictors of R0 resection in patients with stage IIB-IV EOC. Nomogram based on them achieved areas under the ROC curves of 0.908 (95% CI 0.848-0.950) and 0.779 (95% CI 0.659-0.873) in the training and independent validation cohort, respectively. The calibration curves showed good agreement between the nomogram predictions and the actual observations in both cohorts. The nomogram based on overall CT-PCI, serum HE4 level, and NLR could be reliable in predicting R0 resection in EOC patients with stage IIB-IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.